Case number 1:20-cv-01155
Intercept Pharmaceuticals, Inc. et al v. Lupin Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 21, 2023 | 38 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Consent Judgment)(mdb) (Entered: 02/21/2023) (Consent Judgment) (3) |
| Feb 21, 2023 | 38 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Consent Judgment)(mdb) (Entered: 02/21/2023) (Main Document) (1) |
| Apr 4, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. ยง 652(b). (Taylor, Daniel) |
| Sep 10, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Matthew M. Holub for Lupin Limited, Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Sep 9, 2021 | 37 | Holub Pro Hac Certification (1) |
| Sep 9, 2021 | 37 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Matthew M. Holub - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # (1) Holub Pro Hac Certification)(Haney, Megan) |
| Sep 9, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [37] MOTION for Pro Hac Vice Appearance of Attorney Matthew M. Holub filed by Lupin Limited, Lupin Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 9/9/2021. (dlw) |
| Jul 8, 2021 | 36 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Apotex Corp., Apotex Inc..(Ormerod, Eve) |
| Jul 6, 2021 | 35 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Defendants' First Set of Requests for the Production of Documents and Things to Plaintiffs Intercept Pharmaceuticals, Inc. and Intercept Pharma Europe Ltd. (Nos. 1-55); and 2) Defendants' First Set of Joint Interrogatories (Nos. 1-6) filed by Apotex Corp., Apotex Inc..(Ormerod, Eve) |
| Jun 25, 2021 | 34 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Guylaine Hache as co-counsel. Reason for request: no longer associated with the case. (Haney, Megan) |
| Mar 12, 2021 | 33 | SO ORDERED (5) Docket Text: SO ORDERED re (40 in 1:20-cv-01214-MN, 32 in 1:20-cv-01155-MN, 36 in 1:20-cv-01215-MN, 34 in 1:20-cv-01154-MN, 21 in 1:21-cv-00035-MN, 38 in 1:20-cv-01105-MN) Stipulation and Order to Consolidate. ALL FUTURE FILINGS SHALL BE MADE IN C.A. NO. 20-1105. Signed by Judge Maryellen Noreika on 3/12/2021. (dlw) |
| Mar 12, 2021 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:20-cv-01105-MN. (dlw) |
| Mar 10, 2021 | 32 | Stipulation (5) Docket Text: STIPULATION and Order to Consolidate by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd.. (Tigan, Jeremy) |
| Mar 9, 2021 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: Having been advised by the parties of their inability to resolve protective order disputes, IT IS HEREBY ORDERED that a Telephone Conference is set for 4/13/2021 at 12:00 PM before Judge Maryellen Noreika. The opening letter, not to exceed three (3) pages, is due on or before 4/7/2021 and shall attach a copy of the proposed protective order setting forth Plaintiffs' and Defendants' positions. The responsive letter, not to exceed three (3) pages, is due on or before 4/8/2021. Counsel shall provide a dial-in number for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 3/9/2021. (dlw) |
| Mar 3, 2021 | 30 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) |
| Feb 26, 2021 | 29 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to March 5, 2021 - filed by Apotex Corp., Apotex Inc.. (Ormerod, Eve) |
| Feb 26, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (37 in 1:20-cv-01214-MN, 31 in 1:20-cv-01154-MN, 17 in 1:21-cv-00035-MN, 32 in 1:20-cv-01105-MN, 33 in 1:20-cv-01215-MN, 29 in 1:20-cv-01155-MN) STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to March 5, 2021. ORDERED by Judge Maryellen Noreika on 2/26/2021. (dlw) |
| Feb 22, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Should any party (or all parties) desire to discuss mediation and its timing, the party(ies) shall contact Judge Thynges Judicial Administrator to request that a teleconference be scheduled. Ordered by Judge Mary Pat Thynge on 2/22/21. Associated Cases: 1:20-cv-01105-MN, 1:20-cv-01154-MN, 1:20-cv-01155-MN, 1:20-cv-01214-MN, 1:20-cv-01215-MN(cak) |
| Feb 19, 2021 | 27 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to February 26, 2021 - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Feb 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (35 in 1:20-cv-01214-MN, 27 in 1:20-cv-01155-MN, 30 in 1:20-cv-01105-MN, 31 in 1:20-cv-01215-MN, 29 in 1:20-cv-01154-MN, 15 in 1:21-cv-00035-MN) STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to February 26, 2021. ORDERED by Judge Maryellen Noreika on 2/19/2021. (dlw) |
| Feb 12, 2021 | 26 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to February 19, 2021 - filed by Apotex Corp., Apotex Inc.. (Ormerod, Eve) |
| Feb 12, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (29 in 1:20-cv-01105-MN, 26 in 1:20-cv-01155-MN, 30 in 1:20-cv-01215-MN, 34 in 1:20-cv-01214-MN, 28 in 1:20-cv-01154-MN) STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to February 19, 2021. ORDERED by Judge Maryellen Noreika on 2/12/2021. (dlw) |
| Feb 3, 2021 | 25 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Rule 26(A)(1); and (2) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc..(Blumenfeld, Jack) |
| Feb 3, 2021 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan) |
| Jan 27, 2021 | 23 | Scheduling Order (15) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 9/10/2021. Amended Pleadings due by 9/10/2021. Fact Discovery completed by 5/30/2022. Opening Expert Reports due by 7/11/2022. Rebuttal Expert Reports due by 8/22/2022. Reply Expert Reports due by 9/26/2022. Daubert Motions due by 11/21/2022. Answering Brief due 12/12/2022. Reply Brief due 12/20/2022. Claim Construction Opening Brief served by 10/27/2021. Claim Construction Answering Brief served by 12/1/2021. Claim Construction Reply Brief served by 1/7/2022. Claim Construction Surreply Brief served by 1/28/2022. Joint Claim Construction Brief filed by 2/2/2022. A Markman Hearing is set for 3/4/2022 at 02:00 PM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 2/14/2023 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 2/27/2023 at 09:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 1/27/2021. (dlw) |
| Jan 27, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:20-cv-01105-MN, 1:20-cv-01154-MN, 1:20-cv-01155-MN, 1:20-cv-01214-MN, 1:20-cv-01215-MN(cak) |
| Jan 22, 2021 | 22 | Proposed Order (15) Docket Text: PROPOSED ORDER // Scheduling Order by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 1/25/2021 (dlw). |
| Jan 20, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (25 in 1:20-cv-01215-MN, 28 in 1:20-cv-01214-MN, 23 in 1:20-cv-01154-MN, 21 in 1:20-cv-01155-MN) STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order to January 22, 2021. ORDERED by Judge Maryellen Noreika on 1/20/2021. (dlw) |
| Jan 19, 2021 | 21 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order to January 22, 2021 - filed by Apotex Corp., Apotex Inc.. (Belgam, Neal) |
| Jan 13, 2021 | 20 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Douglas Behrens - filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd.. (Blumenfeld, Jack) |
| Jan 13, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (20 in 1:20-cv-01155-MN, 24 in 1:20-cv-01215-MN, 23 in 1:20-cv-01105-MN, 24 in 1:20-cv-01214-MN, 22 in 1:20-cv-01154-MN) MOTION for Pro Hac Vice Appearance of Attorney Douglas Behrens filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd., Intercept Pharma Europe LTD. ORDERED by Judge Maryellen Noreika on 1/13/2021. (dlw) |
| Jan 11, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (19 in 1:20-cv-01155-MN, 22 in 1:20-cv-01105-MN, 23 in 1:20-cv-01215-MN, 23 in 1:20-cv-01214-MN, 21 in 1:20-cv-01154-MN) STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order to January 19, 2021. ORDERED by Judge Maryellen Noreika on 1/11/2021. (dlw) |
| Jan 11, 2021 | 19 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order to January 19, 2021 - filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) |
| Dec 22, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (20 in 1:20-cv-01214-MN, 22 in 1:20-cv-01215-MN, 18 in 1:20-cv-01155-MN, 21 in 1:20-cv-01105-MN, 20 in 1:20-cv-01154-MN) STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to January 11, 2021. ORDERED by Judge Maryellen Noreika on 12/22/2020. (dlw) |
| Dec 22, 2020 | 18 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to January 11, 2021 - filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc.. (Blumenfeld, Jack) |
| Dec 21, 2020 | 17 | Answer to Counterclaim (20) Docket Text: ANSWER to [13] Answer to Amended Complaint, Counterclaim // Answer to Counterclaims by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc. (Blumenfeld, Jack) Modified on 12/22/2020 (dlw). |
| Dec 1, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER - IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed, coordinated order, including a proposal for the length and timing of trial, to the Court no later than thirty (30) days from the date of this Order. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms). If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 12/1/2020. (dlw) |
| Nov 30, 2020 | 15 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,751,349 . (Phillips, John) |
| Nov 30, 2020 | 14 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent no parent corporation for Lupin Limited; Corporate Parent Lupin Limited for Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| Nov 30, 2020 | 13 | Exhibit A (107) |
| Nov 30, 2020 | 13 | Main Document (40) Docket Text: ANSWER to Amended Complaint, re: [11] Amended Complaint, Affirmative Defenses, and COUNTERCLAIM against Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc. by Lupin Pharmaceuticals, Inc., Lupin Limited. (Attachments: # (1) Exhibit A)(Phillips, John) Modified on 12/1/2020 (dlw). |
| Nov 12, 2020 | 12 | Patent/Trademark Report to Commissioner (1) Docket Text: Amended Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 9,238,673 B2; 10,047,117 B2; 10,052,337 B2; 10,174,073 B2; RE48,286 E; 10,758,549 B2. (Blumenfeld, Jack) Modified on 11/13/2020 (dlw). |
| Nov 12, 2020 | 11 | Redline Comparison (34) |
| Nov 12, 2020 | 11 | Exhibits A-G (524) |
| Nov 12, 2020 | 11 | Main Document (30) Docket Text: First AMENDED COMPLAINT against Lupin Limited, Lupin Pharmaceuticals, Inc.- filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Limited. (Attachments: # (1) Exhibits A-G)(Blumenfeld, Jack) (Additional attachment(s) added on 11/13/2020: # (2) Redline Comparison) (dlw). |
| Nov 12, 2020 | 11 | Amended Complaint* (1) |
| Sep 16, 2020 | 10 | Malik Pro Hac Certification (1) |
| Sep 16, 2020 | 10 | Janusz Pro Hac Certification (1) |
| Sep 16, 2020 | 10 | Soderstrom Pro Hac Certification (1) |
| Sep 16, 2020 | 10 | Mukerjee Pro Hac Certification (1) |
| Sep 16, 2020 | 10 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Deepro Mukerjee, Lance Soderstrom, Joseph M. Janusz, Jitendra Malik, Ph.D. and Guylaine Hache - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # (1) Mukerjee Pro Hac Certification, # (2) Soderstrom Pro Hac Certification, # (3) Janusz Pro Hac Certification, # (4) Malik Pro Hac Certification, # (5) Hache Pro Hac Certification)(Haney, Megan) |
| Sep 16, 2020 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Limited: For Lupin Limited waiver sent on 9/15/2020, answer due 11/16/2020. (Blumenfeld, Jack) |
| Sep 16, 2020 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Limited: For Lupin Pharmaceuticals, Inc. waiver sent on 9/15/2020, answer due 11/16/2020. (Blumenfeld, Jack) |
| Sep 16, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Deepro R. Mukerjee, Lance A. Soderstrom, Joseph M. Janusz, Jitendra Malik, Guylaine Hache for Lupin Limited and Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Sep 16, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [10] MOTION for Pro Hac Vice Appearance of Attorney Deepro Mukerjee, Lance Soderstrom, Joseph M. Janusz, Jitendra Malik, Ph.D. and Guylaine Hache filed by Lupin Limited, Lupin Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 9/16/2020. (dlw) |
| Sep 16, 2020 | 10 | Hache Pro Hac Certification (1) |
| Sep 15, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Mary Swears for Intercept Pharma Europe Limited and Intercept Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01154-MN, 1:20-cv-01155-MN, 1:20-cv-01214-UNA, 1:20-cv-01215-UNA(kmd) |
| Sep 15, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (7 in 1:20-cv-01154-MN, 7 in 1:20-cv-01215-UNA, 7 in 1:20-cv-01214-UNA, 7 in 1:20-cv-01155-MN) MOTION for Pro Hac Vice Appearance of Attorney Christopher Sipes, Jeffrey B. Elikan, Megan Keane, Jeremy Cobb, Laura Dolbow, and Mary Swears filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Limited, Intercept Pharma Europe Ltd. ORDERED by Judge Maryellen Noreika on 9/15/2020. (dlw) |
| Sep 14, 2020 | 7 | Motion for Leave to Appear Pro Hac Vice (9) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher Sipes, Jeffrey B. Elikan, Megan Keane, Jeremy Cobb, Laura Dolbow, and Mary Swears - filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd.. (Tigan, Jeremy) |
| Sep 2, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. Associated Cases: 1:20-cv-01154-MN, 1:20-cv-01155-MN (rjb) |
| Aug 28, 2020 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (nmg) |
| Aug 28, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Intercept Pharmaceuticals, Inc. for Intercept Pharma Europe Limited filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc.. (nmg) |
| Aug 28, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673 B2; 10,047,117 B2; 10,052,337 B2; 10,174,073 B2; 7,138,390 B2. (nmg) |
| Aug 28, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Not earlier than 7/16/2020. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/27/2023. (nmg) |
| Aug 28, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Aug 28, 2020 | 1 | Civil Cover Sheet (1) |
| Aug 28, 2020 | 1 | Complaint* (1) |
| Aug 28, 2020 | 1 | Exhibit A-F (415) |
| Aug 28, 2020 | 1 | Main Document (24) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3162926.) - filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Limited. (Attachments: # (1) Exhibit A-F, # (2) Civil Cover Sheet)(nmg) |
